Your session is about to expire
← Back to Search
RECELL for Carbon Dioxide Laser Recovery
Study Summary
This trial will test whether using a person's own cells to treat side effects of CO2 laser treatment can reduce healing time.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have had CO2 laser treatment around my mouth.I am 18 years old or older.I am getting a facelift and CO2 laser treatment around my mouth.You are allergic to any of the ingredients in the medication.
- Group 1: Left receives ReCell (B)
- Group 2: Right receives ReCell (A)
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this scientific experiment still enrolling participants?
"Visiting clinicaltrials.gov, we can confirm that this study is not accepting new participants at present, as the last update to it occurred on November 27th 2022. Despite its lack of recruitment activity, there are currently 6 other medical studies looking for patients right now."
Are elderly individuals being included in the recruitment process of this research?
"Eligible participants for this medical research must be aged 18 or older but no more than 99 years old."
To what extent might this treatment be hazardous to those engaging in it?
"The safety of this particular therapeutic intervention is deemed as level 3 due to it being a Phase 4 trial, indicating the approval and extensive clinical research that has already been conducted."
Who qualifies to partake in this investigation?
"This trial is aiming to accept 10 participants, ranging from 18 years of age to 99. The key inclusion criteria for enrolment include: adults aged over 18; Fitzpatrick Score 1 or 2 skin type; and a current carbon dioxide laser treatment related facelift procedure."
Share this study with friends
Copy Link
Messenger